TWD
DSGN icon

True Wealth Design’s Design Therapeutics DSGN Stock Holding History

True Wealth Design’s Portfolio DSGN Stock Details DSGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$261 Buy
18
+17
+1,700% +$212 ﹤0.01% 2392
2026
Q1 		$11 Hold
1
– – ﹤0.01% 2664
2025
Q4 		$10 Buy
+1
New +$8 ﹤0.01% 2521

Other funds holding DSGN

YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
APW
Allied Private Wealth Boca Raton, Florida $156M AUM
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

True Wealth Design's DSGN Position: Q2 2026 in Review

True Wealth Design increased its Design Therapeutics (DSGN) stake by 1,700% in Q2 2026, buying an estimated $212 and bringing the position to 18 shares worth $261. The position accounts for ﹤0.01% of the portfolio, ranked #2392.

True Wealth Design first reported a position in DSGN in Q4 2025 and has held it in 3 quarters since. 8 funds tracked by Wall St. Rank hold DSGN as of Q2 2026.

  • True Wealth Design held 18 shares of Design Therapeutics worth $261 as of Q2 2026.
  • True Wealth Design bought 17 Design Therapeutics shares in Q2 2026, an estimated $212.
  • Design Therapeutics made up ﹤0.01% of True Wealth Design's portfolio in Q2 2026, its #2392 holding.
  • True Wealth Design first reported a position in Design Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • 8 funds tracked by Wall St. Rank held Design Therapeutics as of Q2 2026.

Based on True Wealth Design's 13F filing for Q2 2026, filed 16 Jul 2026.